{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:43:19Z","timestamp":1791855799101,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1053\/j.ajkd.2025.09.021","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:06:21Z","timestamp":1765037181000},"page":"665-676.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Response to Rituximab as a Maintenance Therapy in Adult Idiopathic Nephrotic Syndrome: A French Multicenter Cohort Study"],"prefix":"10.1053","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4210-3248","authenticated-orcid":false,"given":"Manuel","family":"Laslandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Lorent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Brilland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugoline","family":"Boulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9onard","family":"Golbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Barbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Grellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Larmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Pfirmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Thierry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Dantal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-2164","authenticated-orcid":false,"given":"Christophe","family":"Masset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.ajkd.2025.09.021_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2025.09.021_bib2","first-page":"18","article-title":"Adult minimal change nephropathy: experience of the collaborative study of glomerular disease","volume":"97","author":"Coggins","year":"1986","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"5720","key":"10.1053\/j.ajkd.2025.09.021_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/bmj.3.5720.421","article-title":"Controlled trial of prednisone in adult patients with the nephrotic syndrome","volume":"3","author":"Black","year":"1970","journal-title":"Br Med J"},{"issue":"1","key":"10.1053\/j.ajkd.2025.09.021_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/140.1.1","article-title":"Assessment of serum factor B, serum opsonins, granulocyte chemotaxis, and infection in nephrotic syndrome of children","volume":"140","author":"Anderson","year":"1979","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2025.09.021_bib5","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00467-015-3136-0","article-title":"A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome","volume":"30","author":"Mendon\u00e7a","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2025.09.021_bib6","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2006111300","article-title":"Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum","volume":"18","author":"Glassock","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2025.09.021_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: clinical characteristics, treatment, and outcomes","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2025.09.021_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4192578","article-title":"Treatment strategies of adult primary focal segmental glomerulosclerosis: a systematic review focusing on the last two decades","volume":"2016","author":"Beer","year":"2016","journal-title":"Biomed Res Int"},{"issue":"10","key":"10.1053\/j.ajkd.2025.09.021_bib9","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2215\/CJN.05691108","article-title":"Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children","volume":"4","author":"Kyrieleis","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.09.021_bib10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1681\/ASN.V85824","article-title":"Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults","volume":"8","author":"Tune","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2025.09.021_bib11","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2215\/CJN.01520209","article-title":"Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome","volume":"4","author":"Kengne","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7880","key":"10.1053\/j.ajkd.2025.09.021_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T-cell function","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2025.09.021_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.V103529","article-title":"Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse","volume":"10","author":"Yap","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2025.09.021_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102671","article-title":"Rituximab in adult minimal change disease and focal segmental glomerulosclerosis: what is known and what is still unknown?","volume":"19","author":"Gauckler","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1053\/j.ajkd.2025.09.021_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.1991.232","article-title":"A glomerular permeability factor produced by human T cell hybridomas","volume":"40","author":"Koyama","year":"1991","journal-title":"Kidney Int"},{"issue":"18","key":"10.1053\/j.ajkd.2025.09.021_bib16","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1182\/blood-2009-11-251132","article-title":"Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes","volume":"115","author":"Audard","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.ajkd.2025.09.021_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40620-017-0464-0","article-title":"Monoclonal B lymphocytosis and minimal change disease: a new monoclonal B-cell disorder of renal significance?","volume":"31","author":"Wynsberghe","year":"2018","journal-title":"J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.09.021_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00467-018-4095-z","article-title":"B cell phenotype in pediatric idiopathic nephrotic syndrome","volume":"34","author":"Colucci","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2025.09.021_bib19","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2025.09.021_bib20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.2012.444","article-title":"Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease","volume":"83","author":"Munyentwali","year":"2013","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2025.09.021_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12882-020-01797-7","article-title":"Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis","volume":"21","author":"Hansrivijit","year":"2020","journal-title":"BMC Nephrol"},{"issue":"9950","key":"10.1053\/j.ajkd.2025.09.021_bib22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ajkd.2025.09.021_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.09.021_bib24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa2314471","article-title":"Autoantibodies targeting nephrin in podocytopathies","volume":"391","author":"Hengel","year":"2024","journal-title":"N Engl J Med"},{"issue":"47","key":"10.1053\/j.ajkd.2025.09.021_bib25","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"issue":"8","key":"10.1053\/j.ajkd.2025.09.021_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapediatrics.2018.1323","article-title":"Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: a randomized clinical trial","volume":"172","author":"Basu","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"7","key":"10.1053\/j.ajkd.2025.09.021_bib27","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","article-title":"Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children","volume":"24","author":"Kamei","year":"2009","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2025.09.021_bib28","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","article-title":"Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report","volume":"5","author":"Gulati","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2025.09.021_bib29","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/ndt\/gfaa133","article-title":"Comparison of treatment options in adults with frequently relapsing or steroid-dependent minimal change disease","volume":"36","author":"Heybeli","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2025.09.021_bib30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12882-021-02437-4","article-title":"Extended infusion of rituximab combined with steroids is effective in inducing remission and reducing relapse in adult minimal change disease","volume":"22","author":"Liu","year":"2021","journal-title":"BMC Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2025.09.021_bib31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/nep.13717","article-title":"Rituximab in maintaining remission in adults with podocytopathy","volume":"25","author":"Ramachandran","year":"2020","journal-title":"Nephrology (Carlton)"},{"issue":"4S","key":"10.1053\/j.ajkd.2025.09.021_bib32","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"issue":"282","key":"10.1053\/j.ajkd.2025.09.021_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"5","key":"10.1053\/j.ajkd.2025.09.021_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"6","key":"10.1053\/j.ajkd.2025.09.021_bib35","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.ajkd.2025.09.021_bib36","first-page":"1","article-title":"ipw: An R package for inverse probability weighting","volume":"43","author":"Wal WM van der","year":"2011","journal-title":"J Stat Softw"},{"issue":"1","key":"10.1053\/j.ajkd.2025.09.021_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12882-023-03092-7","article-title":"Efficacy of low-dose rituximab in minimal change disease and prevention of relapse","volume":"24","author":"Zhang","year":"2023","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.09.021_bib38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/ckj\/sfaa191","article-title":"Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis","volume":"14","author":"Xue","year":"2021","journal-title":"Clin Kidney J"},{"issue":"4","key":"10.1053\/j.ajkd.2025.09.021_bib39","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1681\/ASN.0000000520","article-title":"Long-term outcomes of rituximab-treated adult patients with podocytopathies","volume":"36","author":"Gauckler","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.09.021_bib40","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/ndt\/gfs515","article-title":"Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults","volume":"28","author":"Takei","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2025.09.021_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12882-024-03576-0","article-title":"A randomised, 2-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD\/FSGS (TURING)","volume":"25","author":"C Willcocks","year":"2024","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2025.09.021_bib42","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.kint.2024.09.011","article-title":"An international, multi-center study evaluated rituximab therapy in childhood steroid-resistant nephrotic syndrome","volume":"106","author":"Chan","year":"2024","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2025.09.021_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000535010","article-title":"Efficacy of rituximab for minimal change disease and focal segmental glomerulosclerosis with frequently relapsing or steroid-dependent nephrotic syndrome in adults: a Chinese multicenter retrospective study","volume":"55","author":"Lan","year":"2024","journal-title":"Am J Nephrol"},{"issue":"24","key":"10.1053\/j.ajkd.2025.09.021_bib44","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.3390\/jcm10245847","article-title":"Rituximab therapy for adults with nephrotic syndromes: standard schedules or B cell-targeted therapy?","volume":"10","author":"Del Vecchio","year":"2021","journal-title":"J Clin Med"},{"issue":"10","key":"10.1053\/j.ajkd.2025.09.021_bib45","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1681\/ASN.2014070640","article-title":"Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy","volume":"26","author":"Ruggenenti","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.09.021_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2025.09.021_bib50","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ki.2011.195","article-title":"Clinical trial of focal segmental glomerulosclerosis in children and young adults","volume":"80","author":"Gipson","year":"2011","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862501176X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862501176X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:54:31Z","timestamp":1778086471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263862501176X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S027263862501176X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.09.021","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to Rituximab as a Maintenance Therapy in Adult Idiopathic Nephrotic Syndrome: A French Multicenter Cohort Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 National Kidney Foundation, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}